Braylin has anti-inflammatory, antinociceptive and immunomodulatory effects, which possibly act through the Glucocorticoid Receptor activation and by inhibition of the transcriptional activity of NF-?oB. Braylin is also a phosphodiesteRase-4 inhibitor, it could represent an ideal prototype of Glucocorticoid Receptor ligand, able to induce synergic immunomodulatory effects.

Braylin has anti-inflammatory, antinociceptive and immunomodulatory effects, which possibly act through the glucocorticoid receptor activation and by inhibition of the transcriptional activity of NF-IoB. Braylin is also a phosphodiesterase-4 inhibitor, it could represent an ideal prototype of glucocorticoid receptor ligand, able to induce synergic immunomodulatory effects.

6054-10-0

C15H14O4

258.27

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years